Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Sep 15;214(6):825-7.
doi: 10.1093/infdis/jiw068. Epub 2016 Feb 16.

Dengue Vaccine: The Need, the Challenges, and Progress

Affiliations
Editorial

Dengue Vaccine: The Need, the Challenges, and Progress

Alan L Rothman et al. J Infect Dis. .
No abstract available

Keywords: dengue; dengue vaccine; live virus vaccine; protective immunity; vaccine clinical trial.

PubMed Disclaimer

Comment on

References

    1. Thomas SJ, Rothman AL. Trials and tribulations on the path to developing a dengue vaccine. Vaccine 2015; 33(suppl 4):D24–31. - PubMed
    1. Bhatt S, Gething PW, Brady OJ et al. . The global distribution and burden of dengue. Nature 2013; 496:504–7. - PMC - PubMed
    1. Hadinegoro SR, Arredondo-Garcia JL, Capeding MR et al. . Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. New Engl J Med 2015; 373:1195–206. - PubMed
    1. Durbin AP, Kirkpatrick BD, Pierce KK, Schmidt AC, Whitehead SS. Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine. Vaccine 2011; 29:7242–50. - PMC - PubMed
    1. Durbin AP, Kirkpatrick BD, Pierce KK et al. . A 12-month–interval dosing study in adults indicates that a single dose of the National Institutes of Allergy and Infectious Diseases tetravalent dengue vaccine induces a robust neutralizing antibody response. J Infect Dis 2016; 214:832–5. - PMC - PubMed